Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: Curr Opin Neurol. 2022 Oct 3;35(6):764–771. doi: 10.1097/WCO.0000000000001109

Table 2.

Meningioma: molecular alterations associated with specific morphologies, anatomic locations and grades

Meningioma molecular alteration associated with specific morphology or location
SMARCE1 mutation Clear cell meningioma
BAP1 mutation or deletion Rhabdoid meningioma
 22q deletion and/or NF2 mutation Convexity and (majority) of spinal meningiomas
AKT1, TRAF7, SMO and/or PIK3CA mutations Skull base meningioma
Molecular alterations warranting WHO grade 3 designation (regardless of morphologic features)
TERT promoter mutation
 Homozygous deletion of CDKN2A and/or CDKN2B